NEW YORK, NY / ACCESS Newswire / August 4, 2025 / Pomerantz LLP is investigating claims on behalf of investors of GSK plc ("GSK" or the "Company") (NYSE:GSK). Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether GSK and certain of its officers and/or directors have […]
VAIL, Colo., Aug. 04, 2025 (GLOBE NEWSWIRE) — Each July, Steadman Philippon Research Institute (SPRI) and The Steadman Clinic pause to honor a time-honored tradition–celebrating the accomplishments of outgoing fellows while embracing the arrival of a new class of aspiring surgeons. This year's “Hail and Farewell” ceremony, held on July 31 at Donovan Pavilion, marked
NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your RxSight, Inc. (NASDAQ:RXST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/rxsight-inc-lawsuit-submission-form?prid=159636&wire=1&utm_campaign=28 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or call
“Hail and Farewell” Ceremony Honors Incoming Fellows and Graduating Class of 2024-25 at Steadman Philippon Research Institute and The Steadman Clinic Surgeons specializing in sports medicine, hip preservation and reconstruction, foot and ankle, and spine gather for a momentous send-off and warm welcome at the annual celebration GlobeNewswire August 04, 2025 VAIL, Colo., Aug. 04,
NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Lockheed Martin Corporation (NYSE:LMT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/lockheed-martin-corporation-lawsuit-submission-form?prid=159651&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 4, 2025 / Levi & Korsinsky notifies investors that it has commenced an investigation of Molina Healthcare, Inc. ("Molina Healthcare, Inc.") (NYSE:MOH) concerning possible violations of federal securities laws. Molina provided preliminary financial results on July 7, 2025, for the second quarter 2025, including adjusted earnings for
NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Sarepta Therapeutics, Inc. (NASDAQ:SRPT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/sarepta-lawsuit-submission-form?prid=159638&wire=1&utm_campaign=17 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Reckitt Benckiser Group plc (OTCQX:RBGLY) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/reckitt-benckiser-group-plc-lawsuit-submission-form?prid=159637&wire=1&utm_campaign=22 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com
NEW YORK, NY / ACCESS Newswire / August 4, 2025 / If you suffered a loss on your Novo Nordisk A/S (NYSE:NVO) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/novo-nordisk-a-s-lawsuit-submission-form-3?prid=159648&wire=1&utm_campaign=23 or contact Joseph E. Levi, Esq. via email at jlevi@levikorsinsky.com or
The digital therapeutics market is anticipated to increase due to the growing global burden of chronic conditions such as diabetes, cardiovascular disorders, and obesity is propelling demand for digital therapeutics. These solutions offer scalable, evidence-based interventions to manage and prevent chronic illnesses, thereby reducing healthcare costs and enhancing patient outcomes through continuous monitoring and personalized